SCHEMBL4716885

SCHEMBL4716885

N=C(N)NCc1ccc(CN2CCc3ccccc3C(CC(=O)O)C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2B Q13224 1/20 0.48
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
BACE1 P56817 1/20 0.39
DRD4 P21917 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
F2 P00734 1/20 0.38
LMNA P02545 1/20 0.38
PRMT5 O14744 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715242 0.91 GRIN1 (0.46) SIGMAR1GRIN1GRIN2BMEN1KMT2A
SCHEMBL4716886 0.76 ITGB1 (0.42) MEN1KMT2AHDAC1HDAC6F2
SCHEMBL4715035 0.75 NAMPT (0.43) GRIN1GRIN2BPRMT5WDR77
SCHEMBL4714907 0.72 ITGB3 (0.42) SIGMAR1GRIN1GRIN2BMEN1KMT2A
SCHEMBL6926187 0.69 SIGMAR1 (0.39) SIGMAR1GRIN1GRIN2BMEN1KMT2A
SCHEMBL7697397 0.68 SIGMAR1 (0.64) SIGMAR1GRIN1GRIN2BHDAC1HDAC6
SCHEMBL4715244 0.67 ITGB1 (0.40) MEN1KMT2APRMT5WDR77
SCHEMBL7699455 0.67 SIGMAR1 (0.69) SIGMAR1GRIN1GRIN2B
SCHEMBL14222776 0.66 GRIN1 (0.49) GRIN1GRIN2BPRMT5WDR77
Bicarbonate SCHEMBL27358699 0.65 CYP2D6 (0.56) SIGMAR1GRIN1GRIN2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed
US-6514964-B1 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors AMGEN INC. 2003-02-04 US disclosed